Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.72 | 0.0005 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.005 |
mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |
mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.01 |